Authors: Maria Radu & Klaus Bendtzen, IIR 2005.
Atherosclerosis has long been thought of as a condition caused by the accumulation of lipid-rich plaques in artery walls that physically block the vascular flow, eventually leading to ischemia and later infarction of downstream tissues and organs. It is now widely recognized that atherosclerosis is a chronic inflammatory response to different risk factors, e.g. high plasma cholesterol levels, in particular low-desity lipoprotein (LDL) cholesterol, which is considered one of the culprits for atherosclerosis (1, 2).
Inflammation results from a complex interaction between cells and soluble factors that can arise in any vascularized tissue in response to infectious and noxious stimuli (3, 4). Normally, inflammation leads to recovery and healing with or without scar formation, but if dysregulated, inflammation may by itself cause structural and/or functional tissue damage.